Limiting to anti‐cancer agents, boronic compounds are under investigation as dipeptidyl peptidase 8 and 9 (DPP8/9) inhibitors,[13] serine proteases involved in the development of different tumors and deregulated immune responses and as Histone deacetylase inhibitors. The gene discussed is DPP8; the disease is cancer.